A prominent trend in the protein expression market is the increasing research and development (R&D) activities on recombinant proteins. The technologies that are used to produce recombinant proteins, such as gene cloning and genetic engineering, have revolutionized the life sciences sector and enabled the production of biopharmaceuticals at an industrial scale. Their production on such a large scale has led to their application in disease diagnosis and treatment. Many pharmaceutical companies are focusing on the production of recombinant proteins and their expression systems to support the drug discovery process and develop biotherapeutics.

The major driving factor of the protein expression market is the rising prevalence of chronic diseases, including hepatitis, cardiovascular diseases, chronic obstructive pulmonary disease, and viral infections, such as AIDS. As per the World Health Organization, cardiovascular diseases are the most prevalent among all chronic diseases, accounting for 17.7 million deaths in 2015, of which approximately 6.7 million deaths were due to stroke and 7.4 million were due to coronary heart disease. The market is experiencing growth due to the increasing funding for protein-based R&D to provide better clinical intervention for treating various diseases.

As proteins are responsible for carrying out functions in a cell, and most diseases occur due to protein dysfunction and inactivity, the interest in protein-based research is increasing. To be able to establish a connection between protein expression and therapeutics, many organizations are funding such research. The National Institutes of Health invests $32.3 billion annually in the medical research field and issues grants for various programs pertaining to life sciences.

GLOBAL PROTEIN EXPRESSION MARKET SEGMENTATION
By System

• Prokaryotic expression systems
  • Escherichia coli systems
  • Others
• Mammalian cell expression systems
  • Chinese hamster ovary systems
  • Others
• Insect cell expression systems
  • Baculovirus systems
  • Others
• Yeast expression systems
  • K. Lactic systems
  • Saccharomyces systems
  • Pichia systems
  • Others
• Cell-free expression systems
• Algal-based expression systems

By Product and Services

• Reagents 
• Expression vectors
• Competent cells
• Services
• Instruments

By Application

• Therapeutic
• Industrial
• Research

By End User

• Pharmaceutical and biotechnology companies 
• Academic research institutes
• Contract research organizations
• Others

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle-East and Africa
  • South Africa
  • Rest of Middle East and Africa